Terms: = Head and neck cancer AND PR, PGR, progesterone receptor AND Prognosis
156 results:
1. Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer.
Feng H; Zhang S; Zhou Q; Han F; Du G; Wang L; Yang X; Zhang X; Yu W; Wei F; Hao X; Ren X; Zhao H
Front Immunol; 2024; 15():1302903. PubMed ID: 38500886
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
Zheng J; Zhang H; Li S; Kang Z; Zheng F; Yao Q; Zhang X; Wu Z; Wang J; Fang W; Li J; Chen G; Chen Y; Chen M
BMC Cancer; 2023 Dec; 23(1):1193. PubMed ID: 38053017
[TBL] [Abstract] [Full Text] [Related]
3. Real-world data of immunotherapy from China in recurrent or metastatic head and neck squamous cell carcinoma.
Zhang X; Wang P; Chai Y; Zhou X; Li P; Wang X
Am J Otolaryngol; 2024; 45(1):104065. PubMed ID: 37879241
[TBL] [Abstract] [Full Text] [Related]
4. High PGAP3 expression is associated with lymph node metastasis and low CD8
Hao N; Li M; Wang J; Song Y; Zhao Y; Zhang L; Yang X; Chen L; Ma J; Jia Q; Sui F
Pathol Res Pract; 2023 Nov; 251():154890. PubMed ID: 37839361
[TBL] [Abstract] [Full Text] [Related]
5. [Significance of neoadjuvant immunotherapy combined with chemotherapy in the treatment of larynx preservation in locally advanced hypopharyngeal squamous cell carcinoma].
Wu J; Hu G; Li M; Wang Z; Ma W; Wang X; Zhu J; Pan M; Zeng Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Sep; 37(9):715-720;728. PubMed ID: 37830119
[No Abstract] [Full Text] [Related]
6. Noninvasive radiomic analysis of enhanced CT predicts CTLA4 expression and prognosis in head and neck squamous cell carcinoma.
Zhu Y; Wu M
Sci Rep; 2023 Oct; 13(1):16782. PubMed ID: 37798374
[TBL] [Abstract] [Full Text] [Related]
7. A new marker constructed from immune-related lncRNA pairs can be used to predict clinical treatment effects and prognosis: in-depth exploration of underlying mechanisms in HNSCC.
Fan X; Huang Y; Zhong Y; Yan Y; Li J; Fan Y; Xie F; Luo Q; Zhang Z
World J Surg Oncol; 2023 Aug; 21(1):250. PubMed ID: 37592311
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (≥ 6 months) after first-line therapy for recurrent or metastatic head and neck squamous cell carcinoma: a retrospective study.
Vienne A; Collet L; Chevalier T; Borel C; Tardy M; Huguet F; Richard S; Salas S; Saada-Bouzid E; Fayette J; Daste A
BMC Cancer; 2023 Jul; 23(1):663. PubMed ID: 37452287
[TBL] [Abstract] [Full Text] [Related]
9. A Rare Case of Intraosseous Papillary Hemangioma of the head and neck.
Geetha SD; Abdelwahed M; Edelman MC; Buyuk A; Gordon D; Arvind R
Int J Surg Pathol; 2024 Apr; 32(2):418-421. PubMed ID: 37306145
[TBL] [Abstract] [Full Text] [Related]
10. Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival.
Takano EA; Younes MM; Meehan K; Spalding L; Yan M; Allan P; Fox SB; Redfern A; Clouston D; Giles GG; Christie EL; Anderson RL; Zethoven M; Phillips KA; Gorringe K; Britt KL
BMC Cancer; 2023 May; 23(1):459. PubMed ID: 37208678
[TBL] [Abstract] [Full Text] [Related]
11. The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours.
Resteghini C; Castelnuovo P; Nicolai P; Orlandi E; Bossi P; Vischioni B; Schreiber A; Gambazza S; Iacovelli NA; Battaglia P; Guzzo M; Turri-Zanoni M; Mattavelli D; Facchinetti N; Calareso G; Ravanelli M; Facco C; Tartaro T; Licitra L
Eur J Cancer; 2023 Jul; 187():185-194. PubMed ID: 37164774
[TBL] [Abstract] [Full Text] [Related]
12. Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer.
Koukourakis IM; Giakzidis AG; Koukourakis MI
Clin Transl Oncol; 2023 Oct; 25(10):3032-3041. PubMed ID: 37059932
[TBL] [Abstract] [Full Text] [Related]
13. Assessment of Response to Different Induction Chemotherapy Regimens in Locally Advanced Nasopharyngeal Carcinoma.
Lian CL; Zhou R; Zhou Y; Zhou P; Wu SG
Drug Des Devel Ther; 2023; 17():551-562. PubMed ID: 36855516
[TBL] [Abstract] [Full Text] [Related]
14. Long-term effect of photodynamic therapy on oral squamous cell carcinoma and epithelial dysplasia.
Narahara S; Ikeda H; Ogata K; Shido R; Asahina I; Ohba S
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103246. PubMed ID: 36535598
[TBL] [Abstract] [Full Text] [Related]
15. Racial and regional disparities of triple negative breast cancer incidence rates in the United States: An analysis of 2011-2019 NPCR and SEER incidence data.
Zhang W; Bai Y; Sun C; Lv Z; Wang S
Front Public Health; 2022; 10():1058722. PubMed ID: 36530732
[TBL] [Abstract] [Full Text] [Related]
16. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract] [Full Text] [Related]
17. DeepClassPathway: Molecular pathway aware classification using explainable deep learning.
Lombardo E; Hess J; Kurz C; Riboldi M; Marschner S; Baumeister P; Lauber K; Pflugradt U; Walch A; Canis M; Klauschen F; Zitzelsberger H; Belka C; Landry G; Unger K
Eur J Cancer; 2022 Nov; 176():41-49. PubMed ID: 36191385
[TBL] [Abstract] [Full Text] [Related]
18. The prognostic significance of different degrees of resection of skull base chordoma.
Wang Y; Peng Z; Wang Y; Fan R; Zhang H; Jiang W
Clin Transl Oncol; 2022 Dec; 24(12):2441-2452. PubMed ID: 35953670
[TBL] [Abstract] [Full Text] [Related]
19. Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC).
Shi L; You Q; Wang J; Wang H; Li S; Tian R; Yao X; Wu W; Zhang L; Wang F; Lin Y; Li S
Endocrine; 2022 Oct; 78(1):68-76. PubMed ID: 35767182
[TBL] [Abstract] [Full Text] [Related]
20. An Evaluation of Clinical Efficacy of Immune Checkpoint Inhibitors for Patients with Anaplastic Thyroid Carcinoma.
Hatashima A; Archambeau B; Armbruster H; Xu M; Shah M; Konda B; Lott Limbach A; Sukrithan V
Thyroid; 2022 Aug; 32(8):926-936. PubMed ID: 35583228
[No Abstract] [Full Text] [Related]
[Next]